Akso Health Group
AHG
$1.71
-$0.03-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 13.11% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 13.11% | |||
| Cost of Revenue | 0.00% | 23.38% | |||
| Gross Profit | 0.00% | -345.95% | |||
| SG&A Expenses | 0.00% | 296.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 50.18% | |||
| Operating Income | 0.00% | -525.41% | |||
| Income Before Tax | 0.00% | -32,148.33% | |||
| Income Tax Expenses | 0.00% | -79,176.92% | |||
| Earnings from Continuing Operations | 0.00% | -24,306.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 1,655.03% | |||
| Net Income | 0.00% | -22,810.13% | |||
| EBIT | 0.00% | -525.41% | |||
| EBITDA | 0.00% | -138.53% | |||
| EPS Basic | 0.00% | -15,230.77% | |||
| Normalized Basic EPS | 0.00% | -187.50% | |||
| EPS Diluted | 0.00% | -15,446.15% | |||
| Normalized Diluted EPS | 0.00% | -187.50% | |||
| Average Basic Shares Outstanding | 0.00% | 44.70% | |||
| Average Diluted Shares Outstanding | 0.00% | 44.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||